Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Jonsson Comprehensive Cancer Center
OBJECTIVES:
* Determine the efficacy and feasibility of celecoxib for chemoprevention of primary non-small cell lung cancer in high-risk tobacco smokers.
* Determine the safety and long-term side effects of this drug in this population.
OUTLINE: Patients receive oral celecoxib twice daily for 6 months.
Patients are followed at 2 weeks and then at 6 months.
PROJECTED ACCRUAL: A total of 20 patients will be accrued for this study within 6 months.
Age
45–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age \> 45
Smoked \> 20 pack years
You may not be if
Concurrent use of NSAIDs
Hypersensitivity to celecoxib
Documented allergic-type reaction to sulfonamides
History of allergic reaction, urticaria or asthma to aspirin or other NSAIDs
History of liver dysfunction
Hypertension or cardiac conditions aggravated by fluid retention and edema
Previous history of gastrointestinal ulceration, bleeding, or perforation
Renal dysfunction
End stage respiratory disease
Unstable angina
Other malignancy
Pregnancy
Concurrent use of medication known to alter or be affected by alteration of the hepatic p450 2C9 and 2D6 enzymes
Patents with concurrent medical conditions that may interfere with completion of tests, therapy, or the follow up schedule